Archives
-
Atorvastatin Workflows for Cholesterol and Ferroptosis
2026-09-09
Atorvastatin connects cholesterol biosynthesis, vascular signaling, and emerging ferroptosis assays in one experimentally tractable workflow. This guide translates its established cardiovascular research uses into practical HCC model design, dosing, controls, and troubleshooting strategies.
-
EZ Cap™ Cre mRNA: Assay Design Beyond Delivery
2026-09-08
Discover how EZ Cap™ Cre mRNA (m1Ψ) supports transient, loxP-directed recombination in gene editing and functional assays. This guide connects Cre assay design with emerging extrahepatic mRNA delivery while separating cargo performance from delivery-platform effects.
-
N1-Methylpseudouridine and Translation Fidelity
2026-09-08
The reference study directly tested whether N1-methylpseudouridine compromises ribosomal decoding, rather than inferring fidelity from translation yield alone. Its combined biochemical, cellular, RNA-structure, and reverse-transcription analyses indicate that the modification supports accurate protein synthesis while behaving differently from pseudouridine in mismatch stabilization.
-
CDC42 Polarity Controls Intestinal Stem Cell Fate
2026-09-07
The reference study shows that CDC42-dependent apical-basal polarity regulates the intestinal stem cell to transit-amplifying cell transition through a YAP/TAZ-Ereg-mTOR cascade rather than through canonical Wnt signaling alone. Its conditional genetic and pharmacological experiments connect epithelial architecture with crypt proliferation and provide a framework for dissecting intestinal homeostasis.
-
Fulvestrant (ICI 182,780): ER Antagonist Guide
2026-09-07
Fulvestrant, also called ICI 182,780, is a selective estrogen receptor antagonist that promotes ERα downregulation and receptor degradation. Product data and peer-reviewed evidence support its use in ER-signaling studies, MDM2 protein degradation research, chemotherapy-sensitization assays, and endocrine therapy resistance research.
-
N1-Methyl-Pseudouridine-5'-Triphosphate Guide
2026-09-05
Learn how N1-Methyl-Pseudouridine-5'-Triphosphate can improve RNA synthesis workflows, translation testing, and template-RNA stability. The guide also shows how to use controlled nucleotide substitution, junction assays, and repair-pathway logic when adapting RNA experiments to PRINT and retrotransposon insertion research.
-
UTP Solution (100 mM) in RNA Assay Design
2026-09-04
UTP Solution (100 mM) connects controlled nucleotide chemistry with high-confidence RNA measurements. This article interprets the TRIM66 olfactory-receptor study through an assay-design lens while defining practical uses, controls, and limitations for transcription-focused workflows.
-
Busulfan and Lineage Tracing: Reading Injury Correctly
2026-09-04
Busulfan is a DNA alkylating agent whose tissue injury, oxidative stress, and germ-cell effects can complicate interpretation of regeneration assays. This article explains how to pair Busulfan models with dual-recombinase lineage tracing to distinguish cellular depletion from genuine postnatal neo-oogenesis.
-
Controlling Cas9: From mRNA Design to Precision
2026-09-03
Translational genome editing depends not only on guide design, but also on how long, where, and how strongly Cas9 is expressed. This thought-leadership article connects Cap1-capped, m1Ψ-modified Cas9 mRNA with nuclear-export biology, experimental validation, and practical decisions for CRISPR-Cas9 genome editing workflows.
-
Pseudo-UTP: From IVT to Better mRNA Assays
2026-09-03
Pseudo-UTP enables mRNA synthesis with pseudouridine modification. This article connects nucleotide selection to construct design, orthogonal vaccine assays, RNA stability enhancement, and practical quality controls.
-
LG 101506: RXR Modulator Workflows for TNBC
2026-09-02
LG 101506 provides a small-molecule way to perturb RXR biology while profiling PD-L1 stability, glycosylation, and tumor–T-cell interactions. This practical guide connects RXR signaling pathway research with the RBMS1–B4GALT1–PD-L1 mechanism reported in triple-negative breast cancer, while separating established findings from exploratory assay design.
-
Azilsartan (TAK-536) Experimental Workflows
2026-09-02
Azilsartan (TAK-536) gives researchers a selective way to interrogate AT1 signaling in cardiovascular, renin–angiotensin system, and neuroinflammation models. This guide translates a reactive astrocyte–microglia study into practical dosing, conditioned-medium, readout, and troubleshooting workflows.
-
Catalpol: A Mechanism-to-Assay Research Guide
2026-09-01
Catalpol, also known as catalpinoside, is a multi-target iridoid glycoside with applications spanning neuroprotection research, bone biology, ischemic stroke, and fibrosis. This guide translates its signaling profile and pharmacology into practical assay and disease-model decisions.
-
NADH Redox Logic for Translational Assays
2026-09-01
NADH is more than an electron donor: it is an experimentally useful variable linking mitochondrial function, disease modeling, and photocatalytic cancer therapy. This guide explains how to design interpretable NADH assays and translate redox changes into robust biological conclusions.
-
5-Aminolevulinic acid HCl for Heme-Flux Assays
2026-08-31
Use 5-Aminolevulinic acid HCl to turn heme-pathway activity into a controllable experimental variable in Salmonella–macrophage models. The same reagent also supports porphyrin-focused cancer research, but pathway-flux, phagocytosis, cell-death, and fluorescence readouts must be interpreted separately.